{"title":"对 \"免疫检查点抑制剂治疗癌症患者的乙型肝炎功能性治愈:一种前景广阔的策略?\"和 \"肝细胞癌患者是免疫检查点抑制剂治疗乙型肝炎的理想研究人群 \"的回复","authors":"Hsien-Chen Mon , Yi-Hsiang Huang","doi":"10.1016/j.jhep.2024.10.045","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":15888,"journal":{"name":"Journal of Hepatology","volume":"82 3","pages":"Pages e139-e140"},"PeriodicalIF":33.0000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Reply to: “Immune checkpoint inhibitor therapy for functional cure of hepatitis B in cancer patients: A promising strategy?” and “Patients with HCC as an ideal study population to assess immune checkpoint inhibitors in hepatitis B”\",\"authors\":\"Hsien-Chen Mon , Yi-Hsiang Huang\",\"doi\":\"10.1016/j.jhep.2024.10.045\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":15888,\"journal\":{\"name\":\"Journal of Hepatology\",\"volume\":\"82 3\",\"pages\":\"Pages e139-e140\"},\"PeriodicalIF\":33.0000,\"publicationDate\":\"2025-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Hepatology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0168827824027016\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/11/8 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q1\",\"JCRName\":\"GASTROENTEROLOGY & HEPATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Hepatology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0168827824027016","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/11/8 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
Reply to: “Immune checkpoint inhibitor therapy for functional cure of hepatitis B in cancer patients: A promising strategy?” and “Patients with HCC as an ideal study population to assess immune checkpoint inhibitors in hepatitis B”
期刊介绍:
The Journal of Hepatology is the official publication of the European Association for the Study of the Liver (EASL). It is dedicated to presenting clinical and basic research in the field of hepatology through original papers, reviews, case reports, and letters to the Editor. The Journal is published in English and may consider supplements that pass an editorial review.